Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Operating Leases (2021 - 2023)

Dna X's Operating Leases history spans 3 years, with the latest figure at $55000.0 for Q4 2023.

  • Quarterly results put Operating Leases at $55000.0 for Q4 2023, down 16.67% from a year ago — trailing twelve months through Dec 2023 was $55000.0 (down 16.67% YoY), and the annual figure for FY2023 was $55000.0, down 16.67%.
  • Operating Leases for Q4 2023 was $55000.0 at Dna X, down from $120000.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $1.8 million in Q1 2022 to a low of $55000.0 in Q4 2023.
  • The 3-year median for Operating Leases is $183000.0 (2023), against an average of $478000.0.
  • The sharpest move saw Operating Leases changed 0.0% in 2022, then plummeted 88.37% in 2023.
  • Year by year, Operating Leases stood at $66000.0 in 2021, then changed by 0.0% to $66000.0 in 2022, then dropped by 16.67% to $55000.0 in 2023.
  • According to Business Quant data, Operating Leases over the past three periods came in at $55000.0, $120000.0, and $183000.0 for Q4 2023, Q3 2023, and Q2 2023 respectively.